Skip to main content

Mass. High Court Affirms 6-year Limit For Asbestos Claims

Mass. High Court Affirms 6-year Limit For Asbestos Claims

Mass. High Court Affirms 6-year Limit For Asbestos Claims

Introduction

On Friday, March 1, the Massachusetts Supreme Judicial Court ruled that the six-year statute of limitations for construction tort claims was applicable to diseases with long latency periods, such as those linked to asbestos exposure.

As per Massachusetts' construction tort statute of repose, a six-year limit has been put on any and all claims related to the "design, planning, construction of general administration" of the vast majority of construction projects. Counsel for the estate of a plaintiff, who died of mesothelioma in 2016, argued that it was unfair to apply the statute to asbestos exposure victims as the symptoms of the disease take decades to appear.

The legislative motive behind the six-year limit was clear and the ruling stated the statute of limitations was valid even if the defendants were aware of the potential health risks at the time the exposure occurred. A six-judge panel stated that "we recognize that, considering the latency period for asbestos-related illnesses, this will have the regrettable effect of barring all or nearly all tort claims arising from negligence in the use or handling of asbestos in construction-related suits. Nonetheless, the appropriate recourse is in the Legislature, not this court."

Another dangerous side-effect allegedly caused due to asbestos exposure include ovarian cancer, claimed in thousands of lawsuits filed by individuals who used talc-based products for a prolonged time.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Cencora Directors Settle Opioid Oversight Case for $111M

Categories: Opioids

Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of opioids

Study Finds CPAP May Harm Low-Risk Sleep Apnea Patients

A new study has cast doubt on the long-standing belief that continuous positive airway pressure (CPAP) machines significantly reduce heart…

FDA Adds New Warnings on Long-Term Opioid Risks

Categories: Opioids

Federal regulators have raised concerns that many opioid medications were approved for prolonged use without sufficient clinical evidence confirming their safety.

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!